Literature DB >> 33778434

Pre-existing conditions are associated with COVID-19 patients' hospitalization, despite confirmed clearance of SARS-CoV-2 virus.

Colin Pawlowski1, A J Venkatakrishnan1, Eshwan Ramudu1, Christian Kirkup1, Arjun Puranik1, Nikhil Kayal1, Gabriela Berner1, Akash Anand2, Rakesh Barve2, John C O'Horo3, Andrew D Badley3, Venky Soundararajan1,2.   

Abstract

BACKGROUND: Consecutive negative SARS-CoV-2 PCR test results are being considered to estimate viral clearance in COVID-19 patients. However, there are anecdotal reports of hospitalization from protracted COVID-19 complications despite such confirmed viral clearance, presenting a clinical conundrum.
METHODS: We conducted a retrospective analysis of 222 hospitalized COVID-19 patients to compare those that were readmitted post-viral clearance (hospitalized post-clearance cohort, n = 49) with those that were not re-admitted post-viral clearance (non-hospitalized post-clearance cohort, n = 173) between February and October 2020. In order to differentiate these two cohorts, we used neural network models for the 'augmented curation' of comorbidities and complications with positive sentiment in the Electronic Hosptial Records physician notes.
FINDINGS: In the year preceding COVID-19 onset, anemia (n = 13 [26.5%], p-value: 0.007), cardiac arrhythmias (n = 14 [28.6%], p-value: 0.015), and acute kidney injury (n = 7 [14.3%], p-value: 0.030) were significantly enriched in the physician notes of the hospitalized post-clearance cohort.
INTERPRETATION: Overall, this retrospective study highlights specific pre-existing conditions that are associated with higher hospitalization rates in COVID-19 patients despite viral clearance and motivates follow-up prospective research into the associated risk factors. FUNDING: This work was supported by Nference, inc.
© 2021 The Authors.

Entities:  

Year:  2021        PMID: 33778434      PMCID: PMC7985595          DOI: 10.1016/j.eclinm.2021.100793

Source DB:  PubMed          Journal:  EClinicalMedicine        ISSN: 2589-5370


  22 in total

1.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.

Authors:  Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

2.  Positive RT-PCR Test Results in Patients Recovered From COVID-19.

Authors:  Lan Lan; Dan Xu; Guangming Ye; Chen Xia; Shaokang Wang; Yirong Li; Haibo Xu
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

3.  Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factors.

Authors:  Betty P Morales; Ramon Planas; Ramon Bartoli; Rosa M Morillas; Margarita Sala; Eduard Cabré; Irma Casas; Helena Masnou
Journal:  Dig Liver Dis       Date:  2017-03-18       Impact factor: 4.088

4.  Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale.

Authors:  Ronald S Chamberlain; Jaswinder Sond; Krishnaraj Mahendraraj; Christine Sm Lau; Brianna L Siracuse
Journal:  Int J Gen Med       Date:  2018-04-09

5.  Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test.

Authors:  Jianghong An; Xuejiao Liao; Tongyang Xiao; Shen Qian; Jing Yuan; Haocheng Ye; Furong Qi; Chengguang Shen; Lifei Wang; Yang Liu; Xiaoya Cheng; Na Li; Qingxian Cai; Fang Wang; Jun Chen; Guojun Li; Qiu'e Cai; Yingxia Liu; Yunfang Wang; Feng Zhang; Yang Fu; Qing He; Xiaohua Tan; Lei Liu; Zheng Zhang
Journal:  Ann Transl Med       Date:  2020-09

6.  Acute Kidney Injury in Hospitalized Patients Infected with COVID-19 from Wuhan, China: A Retrospective Study.

Authors:  Yujie Dai; Zhifen Liu; Xingguo Du; Honglan Wei; Yang Wu; Hua Li; Ming Tian; Chengxu Li; Xiaohong Song; Weicong Wu; Yuan Cai; Yikai Yu; Shaoxian Hu; Junwu Dong
Journal:  Biomed Res Int       Date:  2021-01-11       Impact factor: 3.411

7.  Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.

Authors:  Kyle G Rodino; Mark J Espy; Seanne P Buckwalter; Robert C Walchak; Jeffery J Germer; Emily Fernholz; Aimee Boerger; Audrey N Schuetz; Joseph D Yao; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

8.  Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.

Authors:  Jing Yang; Ya Zheng; Xi Gou; Ke Pu; Zhaofeng Chen; Qinghong Guo; Rui Ji; Haojia Wang; Yuping Wang; Yongning Zhou
Journal:  Int J Infect Dis       Date:  2020-03-12       Impact factor: 3.623

9.  Prevalence and impact of diabetes among people infected with SARS-CoV-2.

Authors:  G P Fadini; M L Morieri; E Longato; A Avogaro
Journal:  J Endocrinol Invest       Date:  2020-03-28       Impact factor: 4.256

10.  COVID-19 reinfection in a healthcare worker.

Authors:  Marco Bongiovanni
Journal:  J Med Virol       Date:  2021-02-15       Impact factor: 20.693

View more
  5 in total

1.  Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines.

Authors:  Reid McMurry; Patrick Lenehan; Samir Awasthi; Eli Silvert; Arjun Puranik; Colin Pawlowski; A J Venkatakrishnan; Praveen Anand; Vineet Agarwal; John C O'Horo; Gregory J Gores; Amy W Williams; Andrew D Badley; John Halamka; Abinash Virk; Melanie D Swift; Katie Carlson; Deeksha Doddahonnaiah; Anna Metzger; Nikhil Kayal; Gabi Berner; Eshwan Ramudu; Corinne Carpenter; Tyler Wagner; Ajit Rajasekharan; Venky Soundararajan
Journal:  Med (N Y)       Date:  2021-07-01

2.  What might COVID-19 patients experience after recovery? A comprehensive review.

Authors:  Rehab Elhiny; Ali Azeez Al-Jumaili; Mohammed Jamal Yawuz
Journal:  Int J Pharm Pract       Date:  2022-07-26

3.  Preliminary Observations from The FILLED Project (FILipino Lived Experiences during COVID-19).

Authors:  Melanie D Sabado-Liwag; Mayra Zamora; Shenazar Esmundo; Jake Ryann Sumibcay; Patchareeya P Kwan
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

Review 4.  Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.

Authors:  Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

5.  Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.

Authors:  Juan Corchado-Garcia; David Zemmour; Travis Hughes; Hari Bandi; Tudor Cristea-Platon; Patrick Lenehan; Colin Pawlowski; Sairam Bade; John C O'Horo; Gregory J Gores; Amy W Williams; Andrew D Badley; John Halamka; Abinash Virk; Melanie D Swift; Tyler Wagner; Venky Soundararajan
Journal:  JAMA Netw Open       Date:  2021-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.